Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure.

@article{Hamaguchi2010SpironolactoneUA,
  title={Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure.},
  author={Sanae Hamaguchi and Shintaro Kinugawa and Miyuki Tsuchihashi-Makaya and Kazutomo Goto and Daisuke Goto and Takashi Yokota and Satoshi Yamada and Hisashi Yokoshiki and Akira Takeshita and Hiroyuki Tsutsui},
  journal={American heart journal},
  year={2010},
  volume={160 6},
  pages={
          1156-62
        }
}
BACKGROUND The RALES trial demonstrated that spironolactone improved the prognosis of patients with heart failure (HF). However, it is unknown whether the discharge use of spironolactone is associated with better long-term outcomes among hospitalized systolic HF patients in routine clinical practice. We examined the effects of spironolactone use at discharge on mortality and rehospitalization by comparing with outcomes in patients who did not receive spironolactone. METHODS The JCARE-CARD… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study

L. Frankenstein, H. A. Katus, +7 authors on behalf of the Norwegian Heart Failure Registry ste committee
  • European Journal of Clinical Pharmacology
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Treatment of heart failure with spironolactone--trial and tribulations.

  • The New England journal of medicine
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…